Cabozantinib 40mg | Treat Kidney, Liver & Thyroid Cancer

Introduction of Cabozantinib 40mg

Cabozantinib 40 mg is an oral cancer treatment classified as a tyrosine kinase inhibitor (TKI). It is commonly used for the treatment of advanced or metastatic cancers, including:

• Renal Cell Carcinoma (RCC) – advanced kidney cancer
  
  

• Hepatocellular Carcinoma (HCC) – liver cancer after treatment with sorafenib
  
  

• Medullary Thyroid Carcinoma (MTC) – a rare and aggressive thyroid cancer
  
  

Cabozantinib works by inhibiting several protein kinases involved in cancer cell growth, tumor blood vessel formation (angiogenesis), and metastatic spread.

✅ Key Benefits

• Targets multiple cancer-related pathways
  
  

• Effective in advanced-stage kidney, liver, and thyroid cancers
  
  

• Slows or halts tumor progression
  
  

• Administered orally – convenient once-daily dosing
  
  

• Improves progression-free survival and overall response rates
  
  

✅ Possible Side Effects

Common side effects may include:

• Fatigue or weakness
  
  

• Diarrhea
  
  

• Loss of appetite
  
  

• High blood pressure
  
  

• Nausea or vomiting
  
  

• Weight loss
  
  

• Mouth sores
  
  

• Skin rash

✅ Precautions & Warnings

• Not recommended during pregnancy or breastfeeding
  
  

• Avoid in patients with recent surgeries or bleeding disorders
  
  

• Inform your doctor if you have liver or kidney disease
  
  

• Avoid consuming grapefruit juice, which may raise drug levels
  
  

• Monitor blood pressure, liver enzymes, and thyroid function regularly
  
  

✅ Storage Instructions

• Store at 20–25°C (68–77°F)
  
  

• Protect from light, heat, and moisture
  
  

• Keep out of reach of children and pets
  
  

Cabozantinib 40 mg is a powerful anti-cancer therapy that provides meaningful clinical benefits in the management of advanced renal, liver, and thyroid cancers. Its multi-targeted action helps reduce tumor size, delay disease progression, and improve survival outcomes. As a once-daily oral treatment, it offers both efficacy and convenience for patients battling difficult-to-treat cancers.